Magid Abou-Gharbia
Affiliations: | Pharmaceutical Sciences | Temple University, Philadelphia, PA, United States |
Area:
Pharmacology, Inorganic Chemistry, PharmacyWebsite:
https://moulder.temple.edu/about-us/directorGoogle:
"Magid Abou-Gharbia"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Madeleine M. Joullié | grad student | 1979 | Penn | |
| (The synthesis of spirofluorenes of biological interest.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Hewlett ED, Melenski E, Qiu FV, et al. (2020) Facile synthesis of the glucosylceramide synthase inhibitor GZ667161 Tetrahedron Letters. 61: 152352 |
| Childers W, Fan R, Martinez R, et al. (2019) Novel compounds that reverse the disease phenotype in Type 2 Gaucher disease patient-derived cells. Bioorganic & Medicinal Chemistry Letters. 126806 |
| Blass BE, Iyer P, Abou-Gharbia M, et al. (2018) Design and synthesis of functionalized piperazin-1yl-(E)-stilbenes as inhibitors of 17α-hydroxylase-C17,20-lyase (Cyp17). Bioorganic & Medicinal Chemistry Letters |
| Lounsbury N, Eidem T, Colquhoun J, et al. (2018) Novel inhibitors of Staphylococcus aureus RnpA that synergize with mupirocin. Bioorganic & Medicinal Chemistry Letters |
| Al-Ashmawy AAK, Ragab FA, Elokely KM, et al. (2017) Design, synthesis and SAR of new-di-substituted pyridopyrimidines as ATP-competitive dual PI3Kα/mTOR inhibitors. Bioorganic & Medicinal Chemistry Letters |
| Zhang H, Raynal NJ-, Sato T, et al. (2017) Abstract 5064: Identifying novel potential epigenetic anti-cancer drugs from natural compounds using a phenotypic-based screening Cancer Research. 77: 5064-5064 |
| Zhang H, Raynal NJ-, Sato T, et al. (2016) Abstract B50: A phenotypic screen to identify novel potential epigenetic anticancer drugs from natural compounds Cancer Research. 76 |
| Zhang H, Raynal NJ-, Sato T, et al. (2016) Abstract 4701: A phenotypic cell-based screen to identify novel potential epigenetic anti-cancer drugs from natural compounds Cancer Research. 76: 4701-4701 |
| Zhang H, Raynal N, Sato T, et al. (2015) Abstract 3519: A phenotypic screen to discover novel epigenetic anticancer drugs from natural compounds Cancer Research. 75: 3519-3519 |
| Butts A, Koselny K, Chabrier-Roselló Y, et al. (2014) Estrogen receptor antagonists are anti-cryptococcal agents that directly bind EF hand proteins and synergize with fluconazole in vivo. Mbio. 5: e00765-13 |